BRPI1002601A2 - produto e processo de preparo e de nanocápsulas poliméricas caracterizadas contendo cloxacilina aplicáveis ao tratamento da mastite bovina - Google Patents
produto e processo de preparo e de nanocápsulas poliméricas caracterizadas contendo cloxacilina aplicáveis ao tratamento da mastite bovina Download PDFInfo
- Publication number
- BRPI1002601A2 BRPI1002601A2 BRPI1002601-0A BRPI1002601A BRPI1002601A2 BR PI1002601 A2 BRPI1002601 A2 BR PI1002601A2 BR PI1002601 A BRPI1002601 A BR PI1002601A BR PI1002601 A2 BRPI1002601 A2 BR PI1002601A2
- Authority
- BR
- Brazil
- Prior art keywords
- cloxacillin
- treatment
- applicable
- mastitis
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Nanotechnology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRC11002601A BRPI1002601E2 (pt) | 2010-06-01 | 2010-06-01 | composição nanoestruturada de uso veterinário para administração de fármacos |
NZ74075611A NZ740756A (en) | 2010-06-01 | 2011-06-01 | Nanoparticulate composition containing antibiotics for intramammary administration in animals |
PCT/BR2011/000168 WO2011150481A1 (pt) | 2010-06-01 | 2011-06-01 | Composição nanoparticulada contendo antibióticos para administração intramamária de uso animal |
US13/700,963 US10098840B2 (en) | 2010-06-01 | 2011-06-01 | Nanoparticulate composition containing antibiotics for intramammary administration in animals |
ARP110101895A AR083628A1 (es) | 2010-06-01 | 2011-06-01 | Composicion nanoparticulada que contiene antibioticos para administracion intramamaria de uso animal |
EP11788996.4A EP2578209B1 (en) | 2010-06-01 | 2011-06-01 | Nanoparticulate composition containing antibiotics for intramammary administration in animals |
CN201180037401.9A CN103118670B (zh) | 2010-06-01 | 2011-06-01 | 用于动物乳房内施用的含抗生素的纳米颗粒组合物 |
AU2011261098A AU2011261098A1 (en) | 2010-06-01 | 2011-06-01 | Nanoparticulate composition containing antibiotics for intramammary administration in animals |
AU2016204869A AU2016204869A1 (en) | 2010-06-01 | 2016-07-12 | Nanoparticle composition containing antibiotics for intramammary administration in animals |
AU2018200535A AU2018200535B2 (en) | 2010-06-01 | 2018-01-23 | Nanoparticulate composition containing antibiotics for intramammary administration in animals |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRC11002601A BRPI1002601E2 (pt) | 2010-06-01 | 2010-06-01 | composição nanoestruturada de uso veterinário para administração de fármacos |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI1002601A2 true BRPI1002601A2 (pt) | 2012-03-13 |
BRPI1002601B1 BRPI1002601B1 (pt) | 2020-02-11 |
BRPI1002601E2 BRPI1002601E2 (pt) | 2020-06-30 |
Family
ID=45066077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRC11002601A BRPI1002601E2 (pt) | 2010-06-01 | 2010-06-01 | composição nanoestruturada de uso veterinário para administração de fármacos |
Country Status (7)
Country | Link |
---|---|
US (1) | US10098840B2 (pt) |
EP (1) | EP2578209B1 (pt) |
CN (1) | CN103118670B (pt) |
AR (1) | AR083628A1 (pt) |
AU (3) | AU2011261098A1 (pt) |
BR (1) | BRPI1002601E2 (pt) |
WO (1) | WO2011150481A1 (pt) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116570556A (zh) * | 2023-05-17 | 2023-08-11 | 郑州福源动物药业有限公司 | 一种用于治疗畜禽大肠埃希菌和巴氏杆菌感染的复方磺胺氯达嗪钠溶液及其制备方法 |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6285866B2 (ja) | 2011-11-23 | 2018-02-28 | セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. | 天然複合ホルモン補充製剤および療法 |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
EP2819699B1 (en) * | 2012-02-27 | 2019-05-22 | Bayer New Zealand Limited | Controlled release compositions and their methods of use |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
BR102012022036B1 (pt) * | 2012-08-31 | 2019-10-01 | Biolab Sanus Farmacêutica Ltda. | Nanopartícula polimérica de finasterida e minoxidil, processo de sua preparação, suspensão aquosa contendo a mesma, composição farmacêutica, e seu uso |
PT106679B (pt) | 2012-11-27 | 2015-03-25 | Hovione Farmaciencia Sa | Formulações tópicas de tetraciclinas, sua preparação e usos |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
WO2014121343A1 (en) | 2013-02-08 | 2014-08-14 | Luoda Pharma Pty Limited | Methods of treating microbial infections, including mastitis |
US9737538B2 (en) | 2013-02-12 | 2017-08-22 | Bend Research, Inc. | Solid dispersions of low-water solubility actives |
EP2956121B1 (en) | 2013-02-12 | 2018-05-30 | Bend Research, Inc. | Solid dispersions of low-water solubility actives |
CN103222978B (zh) * | 2013-04-02 | 2018-03-06 | 河南省乘风动物保健技术研究所 | 复方磺胺甲噁唑注射液及制备方法 |
EP3103351B1 (en) * | 2014-01-31 | 2018-11-07 | Morishita Jintan Co., Ltd. | Orally administered agent for ruminants and ruminant feed containing same |
US9468626B2 (en) * | 2014-03-13 | 2016-10-18 | Chiesi Farmaceutici S.P.A. | Melatonin-based formulations for parenteral administration |
KR20170005819A (ko) | 2014-05-22 | 2017-01-16 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 천연 복합 호르몬 대체 제형 및 요법 |
CA2951884A1 (en) | 2014-06-11 | 2015-12-17 | Massachusetts Institute Of Technology | Residence structures and related methods |
CN104060401A (zh) * | 2014-07-04 | 2014-09-24 | 东华大学 | 一种释放维生素a的明胶纳米纤维膜的静电纺制备方法 |
EP3171864B1 (en) * | 2014-07-25 | 2020-11-25 | Bend Research, Inc | Nanoparticle formulations of low-water solubility actives |
RU2016141135A (ru) | 2014-07-29 | 2018-08-28 | Терапьютиксмд, Инк. | Трансдермальный крем |
CN105394045B (zh) * | 2014-09-04 | 2020-02-14 | 中国科学院上海巴斯德研究所 | 一种肠道病毒的小分子化合物抑制剂及其应用 |
CN104188964B (zh) * | 2014-09-11 | 2016-07-13 | 保定冀中药业有限公司 | 一种长效苄星氯唑西林乳房注入剂及其制备方法 |
SG11201701928RA (en) | 2014-09-12 | 2017-04-27 | Antibiotx Aps | Antibacterial use of halogenated salicylanilides |
CN104398510B (zh) * | 2014-11-03 | 2016-09-07 | 郑州百瑞动物药业有限公司 | 一种奶牛用苄星氯唑西林乳房注入剂及其制备方法 |
CN104324036A (zh) * | 2014-11-04 | 2015-02-04 | 重庆泰通动物药业有限公司 | 一种注射用磺胺间甲氧嘧啶钠的药物组合物 |
WO2016135075A1 (en) * | 2015-02-23 | 2016-09-01 | Sandoz Ag | Penicillin retard composition for intramuscular injection |
CN104800220B (zh) * | 2015-03-11 | 2017-03-29 | 四川成康动物药业有限公司 | 一种用于解除体内细菌内毒素的药物组方 |
AU2016250668B2 (en) | 2015-04-24 | 2020-07-02 | Sanuwave, Inc. | Tissue disinfection with acoustic pressure shock waves |
GB201509326D0 (en) | 2015-05-29 | 2015-07-15 | Antibio Tx Aps | Novel use |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
CN105941308B (zh) * | 2016-05-06 | 2018-08-17 | 中国医学科学院医学生物学研究所 | 一种通过药物净化和筛选法培育清洁级实验树鼩的方法 |
CN105997857A (zh) * | 2016-06-29 | 2016-10-12 | 冯志清 | 一种用于治疗猪乳房炎的注射液 |
JP2019526611A (ja) | 2016-09-13 | 2019-09-19 | アラーガン、インコーポレイテッドAllergan,Incorporated | 非タンパク質クロストリジウム毒素組成物 |
PL3548001T3 (pl) * | 2016-11-30 | 2022-07-11 | Dukebox Sp. Z O.O. | Sposób wytwarzania roztworu nanocząstek kwasu acetylosalicylowego albo diosminy albo drotaweryny |
CN106667898B (zh) * | 2017-02-22 | 2020-12-22 | 佛山市南海东方澳龙制药有限公司 | 癸氧喹酯制剂及其制备方法和应用 |
CN109528686A (zh) * | 2017-09-22 | 2019-03-29 | 杭州景杰生物科技有限公司 | 利用微混合和卡培他滨两亲性质的卡培他滨的聚合物-脂质混合纳米颗粒 |
CN108403659A (zh) * | 2018-03-01 | 2018-08-17 | 中国科学院过程工程研究所 | 一种硬乳液纳微球及其制备方法和应用 |
CN109320925B (zh) * | 2018-09-29 | 2021-04-09 | 浙江和也健康科技有限公司 | 一种纳米抗菌母粒及其制备方法 |
CN109535720B (zh) * | 2018-10-30 | 2021-02-09 | 武汉市科达云石护理材料有限公司 | 一种苯乙烯挥发抑制剂及其应用 |
CN109432092B (zh) * | 2018-12-07 | 2020-06-09 | 中国农业科学院饲料研究所 | 一种泌乳期复方抗菌制剂及其制备方法与应用 |
CN109498577A (zh) * | 2018-12-24 | 2019-03-22 | 宜昌三峡制药有限公司 | 易溶性复方磺胺氯达嗪钠粉 |
RU2711643C1 (ru) * | 2019-01-10 | 2020-01-17 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Уральский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО УГМУ Минздрава России) | Противомикробная и ранозаживляющая лекарственная форма (варианты) и способ ее получения |
US11419834B2 (en) | 2019-02-25 | 2022-08-23 | Rhode Island Hospital | Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide |
CN110006724B (zh) * | 2019-04-17 | 2021-06-04 | 郑州安图生物工程股份有限公司 | 采用巴氏和革兰氏染色方法检测滴虫用试剂 |
CN111249298B (zh) * | 2020-04-08 | 2021-03-12 | 曲阜师范大学 | 一种含有马杜霉素和顺铂的抗癌药物组合物 |
CN112958285B (zh) * | 2021-02-01 | 2022-08-05 | 核工业北京化工冶金研究院 | 一种用于贝塔石浮选的复配辅助捕收剂及其应用 |
CN112999330B (zh) * | 2021-03-18 | 2023-04-18 | 成都大学 | 苯甲酸雌二醇与缩宫素长效混悬注射液的制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8621484D0 (en) * | 1986-09-05 | 1986-10-15 | Norbrook Lab Ltd | Intramammary infusion |
CA2184242C (en) * | 1994-02-28 | 2000-05-02 | Jorg Kreuter | Drug targeting system, method for preparing same and its use |
ES2093562B1 (es) * | 1995-05-26 | 1997-07-01 | Univ Santiago Compostela | Estabilizacion de sistemas coloidales mediante formacion de complejos ionicos lipido-polisacarido. |
IT1298575B1 (it) * | 1998-02-06 | 2000-01-12 | Vectorpharma Int | Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di |
US7901711B1 (en) * | 2006-04-17 | 2011-03-08 | Gp Medical, Inc. | Nanoparticles for protein/peptide delivery and delivery means thereof |
KR100718329B1 (ko) * | 2005-09-08 | 2007-05-14 | 광주과학기술원 | 다당류로 기능화된 수화젤막을 가지는 나노입자와 이를포함하는 서방형 약물전달시스템 및 그 제조방법 |
PT1834635E (pt) * | 2006-03-13 | 2011-10-13 | Advanced In Vitro Cell Technologies S L | Sistemas estáveis de nanocápsula para a administração de moléculas activas |
CA2729764A1 (en) * | 2008-07-01 | 2010-01-07 | Nitto Denko Corporation | Pharmaceutical composition containing surface-coated microparticles |
-
2010
- 2010-06-01 BR BRC11002601A patent/BRPI1002601E2/pt not_active Application Discontinuation
-
2011
- 2011-06-01 CN CN201180037401.9A patent/CN103118670B/zh active Active
- 2011-06-01 US US13/700,963 patent/US10098840B2/en active Active
- 2011-06-01 WO PCT/BR2011/000168 patent/WO2011150481A1/pt active Application Filing
- 2011-06-01 AU AU2011261098A patent/AU2011261098A1/en not_active Abandoned
- 2011-06-01 AR ARP110101895A patent/AR083628A1/es active IP Right Grant
- 2011-06-01 EP EP11788996.4A patent/EP2578209B1/en active Active
-
2016
- 2016-07-12 AU AU2016204869A patent/AU2016204869A1/en not_active Abandoned
-
2018
- 2018-01-23 AU AU2018200535A patent/AU2018200535B2/en active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116570556A (zh) * | 2023-05-17 | 2023-08-11 | 郑州福源动物药业有限公司 | 一种用于治疗畜禽大肠埃希菌和巴氏杆菌感染的复方磺胺氯达嗪钠溶液及其制备方法 |
CN116570556B (zh) * | 2023-05-17 | 2023-11-07 | 郑州福源动物药业有限公司 | 一种用于治疗畜禽大肠埃希菌和巴氏杆菌感染的复方磺胺氯达嗪钠溶液及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
EP2578209A1 (en) | 2013-04-10 |
WO2011150481A1 (pt) | 2011-12-08 |
AU2018200535A1 (en) | 2018-02-15 |
BRPI1002601B1 (pt) | 2020-02-11 |
AU2011261098A1 (en) | 2013-01-24 |
CN103118670B (zh) | 2021-12-14 |
EP2578209B1 (en) | 2019-08-07 |
AU2016204869A1 (en) | 2016-07-28 |
US20130189368A1 (en) | 2013-07-25 |
AU2018200535B2 (en) | 2019-09-05 |
CN103118670A (zh) | 2013-05-22 |
BRPI1002601E2 (pt) | 2020-06-30 |
US10098840B2 (en) | 2018-10-16 |
AR083628A1 (es) | 2013-03-13 |
EP2578209A4 (en) | 2014-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1002601A2 (pt) | produto e processo de preparo e de nanocápsulas poliméricas caracterizadas contendo cloxacilina aplicáveis ao tratamento da mastite bovina | |
BR112013000675A2 (pt) | nanopartícula, processo para produzir uma nanopartícula compreendendo uma matriz de zeína e um aminoácido básico, processo para produzir uma nanopartícula compreendendo uma matriz de zeína, e um aminoácido básico e um composto biologicamente ativo solúvel em gordura, composição e produto alimentar | |
JP2016521289A5 (pt) | ||
BR112017014649A2 (pt) | ?isolado intestinal humano, e, composição? | |
BR112015028692A8 (pt) | agente preventivo ou terapêutico para mastite de animal ruminante | |
JP2018521007A5 (pt) | ||
BR112015027636A2 (pt) | Uso da composição farmacêutica | |
BR112012030485A2 (pt) | composição para prevenção ou tratamento de osteoporose e processo de fabricação para a mesma | |
RU2015125646A (ru) | Вакцина против внутриутробного заболевания | |
BR112014029515A2 (pt) | vacina de vírus schmallenberg (sbv), métodos de produção e usos da mesma, virus schmallenberg, usos de seus antígenos e composição de matéria | |
CN103768025B (zh) | 氟苯尼考琥珀酸钠可溶性粉及其制备方法和应用 | |
JP2014530223A5 (pt) | ||
EP3141249A3 (en) | Pharmaceutical composition for treating a glycoprotein-related disease | |
CN104382898A (zh) | 一种复方阿莫西林乳房注入剂及其制备方法 | |
Han et al. | Antibacterial effects of purified bee venom against some pathogenic bacteria isolated from dead chickens | |
NZ740756A (en) | Nanoparticulate composition containing antibiotics for intramammary administration in animals | |
BR112014030085A2 (pt) | procedimento de preparação de uma composição veterinária oral agradável ao paladar; e composição veterinária oral agradável ao paladar | |
Heinzl et al. | Secondary plant compound to reduce the use of antibiotics | |
CN102988283A (zh) | 一种土霉素注射液及其制备方法 | |
Kim et al. | The effect of rhythm therapy on recognition, body composition, and physical fitness in elderly with mild dementia | |
CN104055836A (zh) | 皮肤滋养抑菌乳膏 | |
LI | Clinical effect of quadruple scheme combined with bismuth in the treatment of patients with helicobacter pylori | |
Maisa A et al. | Therapeutic effect of lauric acid, a medium chain saturated fatty acid on giardia lamblia in experimentally infected hamsters | |
AR107734A1 (es) | Métodos de tratamiento de diarrea en animales no humanos, neonatales y jóvenes, pre-destete | |
RO134199A3 (ro) | Compoziţie nanocompus pentru administrare intramamară la vaci cu mamită |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/06/2010, OBSERVADAS AS CONDICOES LEGAIS. |
|
B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: |
|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: |
|
B04C | Request for examination: application reinstated [chapter 4.3 patent gazette] |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |